K. Tølbøl

Towards a standard diet-induced and biopsy-confirmed mouse model of non-alcoholic steatohepatitis: Impact of dietary fat source

D. Tabor, J. Jelsing, N. Vrang, 2019, World journal of gastroenterology.

Disease Progression and Pharmacological Intervention in a Nutrient-Deficient Rat Model of Nonalcoholic Steatohepatitis

M. Gillum, J. Jelsing, N. Vrang, 2018, Digestive Diseases and Sciences.

Obese diet-induced mouse models of nonalcoholic steatohepatitis-tracking disease by liver biopsy.

J. Jelsing, N. Vrang, J. Roth, 2016, World journal of hepatology.

Vortioxetine Treatment Reverses Subchronic PCP Treatment-Induced Cognitive Impairments: A Potential Role for Serotonin Receptor-Mediated Regulation of GABA Neurotransmission

C. Sánchez, A. Pehrson, K. Tølbøl, 2018, Front. Pharmacol..

Metabolic and hepatic effects of liraglutide, obeticholic acid and elafibranor in diet-induced obese mouse models of biopsy-confirmed nonalcoholic steatohepatitis

M. Gillum, J. Jelsing, N. Vrang, 2018, World journal of gastroenterology.

Comparative effects of liraglutide, elafibranor and obeticholic acid on NAFLD activity score and fibrosis stage in a diet-induced obese mouse model of biopsy-confirmed NASH

N. Vrang, S. Veidal, M. Feigh, 2017 .